Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer

VernacularTitle:微生物群与肺癌的早期诊断及辅助治疗
Author: Min GAO ¹ ; Jing FENG ; Li WANG ; Hai ZHONG ; Yuting WEN ; Bing WAN ; Xiuwei ZHANG
Author Information

1. 南京医科大学附属江宁医院呼吸与危重症医学科，南京　211100
Keywords: Microbiota; Early diagnosis; Lung neoplasms; Combined modality therapy
From: Journal of International Oncology 2022;49(4):247-251
CountryChina
Language:Chinese
Abstract: Drug-resistance and adverse reaction in the treatment of lung cancer patients are still a difficult problem in modern medicine. Studies have indicated that the abundance, diversity and metabolites of intestinal and pulmonary microbiota can be used to assist in the early diagnosis and monitoring the prognosis of lung cancer. Meanwhile, as combined modality therapies, intestinal microbiota combined with chemotherapy, immunotherapy and targeted therapy can enhance therapeutic effect and reduce adverse reaction. Microbiota exhibits an extensive application prospect in the diagnosis and treatment of lung cancer.